Mycophenolate mofetil and Chlorthalidone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Chlorthalidone (chlorthalidone). Common drug interactions include choking sensation among females and renal impairment among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Chlorthalidone. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Chlorthalidone?

Chlorthalidone has active ingredients of chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 12,482 Chlorthalidone users. Check the latest studies of Chlorthalidone.



On Jul, 27, 2026

91 people who take Mycophenolate mofetil and Chlorthalidone together, and have interactions are studied.

Mycophenolate mofetil and Chlorthalidone drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Chlorthalidone, by gender? *:

female:

  1. Choking sensation (feeling of obstruction in respiratory system)
  2. Cholecystitis (infection of gallbladder)
  3. Chorioretinitis (an inflammation of the choroid (thin pigmented vascular coat of the eye) and retina of the eye)
  4. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
  5. Cough
  6. Decreased appetite
  7. Dehydration (dryness resulting from the removal of water)
  8. Delirium (wild excitement)
  9. Dizziness postural
  10. Dry eye (lack of adequate tears)

male:

  1. Renal impairment (severely reduced kidney function)
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Dehydration (dryness resulting from the removal of water)
  4. Dyspnoea (difficult or laboured respiration)
  5. Herpes zoster
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  7. Interstitial lung disease
  8. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  9. Prostatomegaly (enlargement of the prostate)
  10. Depressed mood

What are the common drug interactions of Mycophenolate Mofetil and Chlorthalidone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Renal impairment (severely reduced kidney function)
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Chronic kidney disease
  4. Fatigue (feeling of tiredness)
  5. Herpes zoster
  6. Kidney transplant rejection

30-39:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)

40-49:

  1. Erythema (redness of the skin)
  2. Gait disturbance
  3. Grip strength decreased
  4. Hip arthroplasty
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Hypokalaemia (low potassium)
  7. International normalised ratio increased
  8. Joint range of motion decreased (disease of joint movement)
  9. Joint stiffness
  10. Mobility decreased (ability to move is reduced)

50-59:

  1. Humerus fracture (injury to the upper arm bone)
  2. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Chronic kidney disease
  6. Death

60+:

  1. Lung disorder (lung disease)
  2. Osteopenia (a condition where bone mineral density is lower than normal)
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  4. Interstitial lung disease
  5. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  6. Prostatomegaly (enlargement of the prostate)
  7. Dizziness
  8. Peripheral swelling
  9. Arthralgia (joint pain)
  10. Arthropathy

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 20 people, 21.98%
  2. Idiopathic Pulmonary Fibrosis (chronic lung disease): 18 people, 19.78%
  3. Tremor (trembling or shaking movements in one or more parts of your body): 14 people, 15.38%
  4. Lung Disorder (lung disease): 12 people, 13.19%
  5. Cough: 11 people, 12.09%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Chlorthalidone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mycophenolate mofetil and Chlorthalidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Chlorthalidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycophenolate mofetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Chlorthalidone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and chlorthalidone (the active ingredients of Mycophenolate mofetil and Chlorthalidone, respectively), and Mycophenolate mofetil and Chlorthalidone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: